Abstract

The morbidity of type 2 diabetes mellitus (T2DM) has been increasing rapidly worldwide. Tangminling pill, consisting of ten Chinese herbal medications, is usually prescribed for T2DM in mainland China. Whether treatment with Tangminling can improve clinical outcomes of T2DM patients was still debated. Four studies comparing Tangminling vs. placebo treatment in T2DM patients were included and 767 T2DM patients were enrolled in our analyses. Tangminling treatment exhibited better efficacy than placebo in reducing hemoglobin A1c (HbA1c) (1.11 vs. 0.32%; pooled weighted mean difference [WMD]: 0.80; 95% confidence interval [CI]: 0.65–0.96; P<0.001), fasting plasma glucose (0.82 vs. −0.40 mM; WMD: 1.10; 95% CI: 0.56–1.64; P<0.001), 2-h postprandial glucose (2-hr PG) (2.81 vs. 1.11 mM; WMD: 1.80; 95% CI: 1.72–1.88; P<0.001), homeostatic model assessment-β level (4.28 vs. 0.41; WMD: 0.44; 95% CI: 0.27–0.61; P<0.001), waist circumference (WC) (1.04 vs. 0.36 cm; WMD: 0.78; 95% CI: 0.37–1.19; P<0.001) and body weight index (0.37 vs. 0.11 kg/m2; WMD: 0.30; 95% CI: −0.00 to 0.61; P=0.05). Tangminling pill might reduce glucose level and body weight and improve β-cell function in T2DM patients. Our study highlights the important role of Tangminling pill in the management of T2DM.

Introduction

Type 2 diabetes mellitus (T2DM) is becoming a crucial threat to human health, with approximately 425 million individuals worldwide in 2017, and it is estimated that the number will exhibit a 45% increase in three decades [1]. T2DM patients might be suffering from pancreatic β-cell dysfunction and reduced insulin sensitivity in target tissues [2,3]. Chronic hyperglycemia causes macrovascular and microvascular complications and remodeling in the heart, kidneys, eyes, and nerves [4–6]. Oral antidiabetic agents, including metformin, sulfonylureas, glucosidase inhibitors, thiazolidinediones, meglitinides, and inhibitors of dipeptidyl peptidase 4, have substantially improved the prognosis of most T2DM patients. However, the efficacy of Western medications remains deficient in certain patients and vastly disproportionate burden on patients in low- and middle-income countries. Hence, complementary or alternative therapies such as traditional Chinese herbal medications are required to prolong life expectancy and improve the quality of life in T2DM patients.

Although traditional Chinese herbal medications have been widely used for more than 2000 years in East Asia and previous studies suggested that some Chinese herbal medications were effective in treating T2DM [7–9], their evidence based on randomized controlled trials (RCTs) is still feeble. Tangminling pill, mainly containing Rhizoma coptidis, Rheum officinale Baill, Scutellaria baicalensis Georgi, and Bupleurum Chinense DC, might reduce blood glucose level and improve pancreatic β-cell function [8,10–12]. However, the studies focusing on the effects of Tangminling pill on T2DM were limited due to insufficient sample sizes and inconclusive results. In our study, we performed a pooled analysis to evaluate the effects of Tangminling pill on blood glucose, body weight, and β-cell function in T2DM patients.

Materials and methods

Preparation of Tangminling pill

The pharmaceutical composition of Tangminling pill comprises extracts of the following ten traditional Chinese herbs: Rhizoma coptidis (Huanglian), Scutellaria baicalensis Georgi (Huangqin), Radix Paeoniae Alba (Baishao), Rheum officinale Baill (Dahuang), Citrus aurantium L (Zhishi), Pinellia ternate (Baixia), Crataegus pinnatifida Bunge (Shanzha), Smoked plum Fructus mume (Wumei), Radix Trichosanthis (Tianhuafen), and Bupleurum Chinense DC (Chaihu), and optionally comprises pharmaceutically acceptable excipient. The method to prepare Tangminling pill and the doses of all the above ten crude herbs have been disclosed to the public (http://www.freepatentsonline.com/8637092.html). It was manufactured and capsulated with specific processing of Chinese herbal medicine in Tasly Pharmaceutical (Tianjin, China), as described previously [8]. There were quantitative control limits for the raw herbs in the final product (the content of berberine in Rhizoma coptidis shall not be <6.0 mg/g and the content of paeoniflorin in Radix Paeoniae Alba shall not be <3.0 mg/g). The chemical composition of Tangminling pill was further analyzed using the high-performance liquid chromatography/mass spectrometry (HPLC/MS) method [8].

Ethics statement

The study project conformed to the ethical rules of the Helsinki Declaration (revised edition in October 2013) and was approved by the Ethics Committee of Shandong University Qilu Hospital (KYLL-201761; date of approval: 15 July 2017).

Data search and selection

Relevant RCTs were identified from the following data sources: Medline, China VIP, China National Knowledge Internet, China Wanfang, and Cochrane library. Literature were searched with the terms (‘Tang-min-ling’ or ‘TM81’ or ‘Tangminling’ or ‘TML’) AND (‘diabetes’ or ‘T2DM’). Publication status, language, and date were not restricted.

We included studies with the following criteria: (i) compared Tangminling treatment vs. placebo treatment in T2DM patients; (ii) RCTs with more than 1-month follow-up durations; and (iii) contained available data to estimate the pooled weighted mean differences (WMDs) and their corresponding 95% confidence intervals (CIs). Studies were excluded as follows: (i) diagnosis of T2DM was not definite; (ii) studies were non-randomized and/or non-double-blinded; (iii) different traditional Chinese medications were compared between two groups; (iv) only symptomatic changes were described without objective laboratory measurements; (v) methodological quality was poor with a Jadad score < 3 as described previously [13]; and (vi) if two articles reported results from the same trial, the article with less information was excluded.

Data extraction

We extracted the following information from retrieved reports using a standardized protocol: author names, publication dates, study designs, countries of origin, subject numbers, subject characteristics at baseline, follow-up durations, concomitant medications, and end points [14]. The literature search and data extraction were performed blindly by two authors (J.C. and Y.L.) according to a standardized approach. All disagreements were resolved by consensus and a third reviewer (P.H.).

Statistical analysis

RevMan software version 5.3 was used for this pooled analysis. The heterogeneity was evaluated by the Cochran’s Q statistic and the inconsistency index (I2). Heterogeneity was considered statistically significant when chi-square P was <0.10 and I2 was >50%. Pooled WMDs with 95% CIs were analyzed, and the difference was considered statistically significant when two-tailed P was <0.05. Moreover, sensitivity analyses were performed to evaluate individual effects and explain possible heterogeneity. Additionally, we calculated the fail-safe number (Nfs; Nfs0.05 = (∑Z/1.64)2 – k, where k is the number of retrieved studies) to assess publication bias [15]. Any Nfs0.05 values smaller than the number of included trials indicated that obvious publication bias existed.

Results

Two hundred and seventy eight potentially literature citations were screened. Only four RCTs with sufficient information were included for analyses, and all the four RCTs were published in full articles updated to December 2017 [8,10–12]. The agreement for literature selection was excellent (κ = 0.93). Seven hundred and sixty seven T2DM patients were enrolled in our pooled analyses, with 71–397 participants in the four eligible trials. The mean ages of the participants ranged from 51.6 to 54.5 years, and the follow-up durations were all 12 weeks. The Jadad scores were five in three of four RCTs [10–12] and four in the left one RCT [8]. The loss to follow-up was <10% in all RCTs. Thus, the methodological quality of the retrieved studies was generally high.

Clinical end points

First, we performed a pooled analysis to evaluate the effect of Tangminling pill on blood glucose level. Blood glucose improvement was evaluated by reductions of hemoglobin A1c (HbA1c), fasting plasma glucose (FPG) and 2-h postprandial glucose (2-hr PG) levels from baseline in all four studies (Table 1). It showed that Tangminling pill significantly reduced HbA1c (1.11 vs. 0.32%, P<0.001), FPG (0.82 vs. −0.40 mM, P<0.001) and 2-hr PG levels (2.81 vs. 1.11 mM, P<0.001) in T2DM patients, as compared with placebo group.

Table 1
Main results of clinical outcomes
OutcomesPlacebo-treated patients, nTangminling pill-treated patients, nWMD (95% CI)P-valueI2 statisticHeterogeneity P-valueReferences
HbA1c 259 440 0.80 [0.65, 0.96] <0.001 0% >0.05 [8,10–12
FPG 259 440 1.10 [0.56, 1.64] <0.001 77% <0.01 [8,10–12
2-hr PG 259 440 1.80 [1,72, 1.88] <0.001 0% >0.05 [8,10–12
BMI 259 440 0.30 [-0.00, 0.61] 0. 05 90% 0.001 [8,10–12
WC 259 440 0.78 [0.37, 1.19] <0.001 63% <0.05 [8,10–12
HOMA-IR 190 373 0.26 [-0.10, 0.62] >0.05 81% <0.01 [8,10,12
HOMA-β 190 494 0.44 [0.27, 0.61] <0.001 36% >0.05 [8,10,12
OutcomesPlacebo-treated patients, nTangminling pill-treated patients, nWMD (95% CI)P-valueI2 statisticHeterogeneity P-valueReferences
HbA1c 259 440 0.80 [0.65, 0.96] <0.001 0% >0.05 [8,10–12
FPG 259 440 1.10 [0.56, 1.64] <0.001 77% <0.01 [8,10–12
2-hr PG 259 440 1.80 [1,72, 1.88] <0.001 0% >0.05 [8,10–12
BMI 259 440 0.30 [-0.00, 0.61] 0. 05 90% 0.001 [8,10–12
WC 259 440 0.78 [0.37, 1.19] <0.001 63% <0.05 [8,10–12
HOMA-IR 190 373 0.26 [-0.10, 0.62] >0.05 81% <0.01 [8,10,12
HOMA-β 190 494 0.44 [0.27, 0.61] <0.001 36% >0.05 [8,10,12

Abbreviations: BMI, body weight index; HOMA-β, homeostatic model assessment to β-cell function; HOMA-IR, homeostatic model assessment to quantitate insulin resistance; PG, postprandial plasma glucose; WC, waist circumference.

Also, Tangminling pill significantly ameliorated obesity, which was expressed as reductions of waist circumference (WC) and body mass index (BMI) in T2DM patients (Table 1). Tangminling significantly reduced WC (1.04 vs. 0.36 cm, P<0.001) and BMI (0.37 vs. 0.11 kg/m2, P=0.05) from baseline in comparison with placebo treatment in T2DM patients.

Furthermore, it showed that Tangminling pill significantly improved pancreatic β-cell function, expressed as homeostatic model assessment (HOMA)-β decrease from baseline (Table 1). Although there was no difference in reducing HOMA-insulin resistance (IR) between Tangminling and placebo groups (0.16 vs. −0.16, P>0.05), Tangminling significantly decreased HOMA-β level from baseline as compared with placebo (4.28 vs. 0.41, P<0.001).

Furthermore, the safety of Tangminling pill was also confirmed, without serious adverse events reported in all the four RCTs.

Sensitivity analyses

Heterogeneity was well-addressed in terms of HbA1c (I2 = 0%), 2h-PG (I2 = 0%), and HOMA-β (I2 = 36%). However, significant heterogeneity was existed in terms of FPG (I2 = 77%), BMI (I2 = 90%), WC (I2 = 63%), and HOMA-IR (I2 = 81%). Alterations in pooled WMDs were not significant after excluding the study with the largest sample size [8] (data not shown). Thereafter, subgroup analyses according to FPG, BMI, WC, and HOMA-IR were conducted (Table 2). The heterogeneity among trials was partially explained by the variability in doses of the medication and subject numbers.

Table 2
Subgroup analyses concerning FPG, BMI, WC, and HOMA-IR
OutcomeSubgroupPatients, nWMD (95% CI)P-valueI2 statisticHeterogeneity P-valueReferences
FPG Adjustment for doses 
 12 g 208 0.99 [0.37, 1.62] <0.01 13% >0.05 [11,12
 6 g 628 1.22 [0.39, 2.04] <0.01 86% <0.001 [8,10,11
 Adjustment for subject numbers 
 >100 672 1.01 [0.41, 1.61] 0.001 77% 0.01 [8,11
 ≤100 164 1.66 [1.04, 2.28] <0.001 0% >0.05 [10,12
BMI Adjustment for doses 
 12 g 208 0.21 [−0.31, 0.73] >0.05 0% >0.05 [11,12
 6 g 628 0.33 [−0.33, 0.69] >0.05 95% <0.001 [8,10,11
 Adjustment for subject numbers 
 >100 672 0.53 [0.36, 0.70] <0.001 13% >0.05 [8,11
 ≤100 164 0.16 [0.03, 0.29] 0.01 0% >0.05 [10,12
WC Adjustment for doses 
 12 g 208 0.57 [0.06, 1.08] <0.05 0% >0.05 [11,12
 6 g 628 0.84 [0.32, 1.36] <0.01 70% 0.04 [8,10,11
 Adjustment for subject numbers 
 >100 672 1.10 [1.08, 1.12] <0.001 0% >0.05 [8,11
 ≤100 164 0.53 [0.19, 0.88] <0.01 0% >0.05 [10,12
HOMA-IR Adjustment for doses 
 12 g 71 0.68 [0.19, 1.17] <0.01 NA NA [11,12
 6 g 492 0.10 [−0.17, 0.38] >0.05 71% >0.05 [8,10,11
 Adjustment for subject numbers 
 >100 399 0.00 [−0.02, 0.02] >0.05 NA NA [8
 ≤100 164 0.40 [0.14, 0.66] <0.01 43% >0.05 [10,12
OutcomeSubgroupPatients, nWMD (95% CI)P-valueI2 statisticHeterogeneity P-valueReferences
FPG Adjustment for doses 
 12 g 208 0.99 [0.37, 1.62] <0.01 13% >0.05 [11,12
 6 g 628 1.22 [0.39, 2.04] <0.01 86% <0.001 [8,10,11
 Adjustment for subject numbers 
 >100 672 1.01 [0.41, 1.61] 0.001 77% 0.01 [8,11
 ≤100 164 1.66 [1.04, 2.28] <0.001 0% >0.05 [10,12
BMI Adjustment for doses 
 12 g 208 0.21 [−0.31, 0.73] >0.05 0% >0.05 [11,12
 6 g 628 0.33 [−0.33, 0.69] >0.05 95% <0.001 [8,10,11
 Adjustment for subject numbers 
 >100 672 0.53 [0.36, 0.70] <0.001 13% >0.05 [8,11
 ≤100 164 0.16 [0.03, 0.29] 0.01 0% >0.05 [10,12
WC Adjustment for doses 
 12 g 208 0.57 [0.06, 1.08] <0.05 0% >0.05 [11,12
 6 g 628 0.84 [0.32, 1.36] <0.01 70% 0.04 [8,10,11
 Adjustment for subject numbers 
 >100 672 1.10 [1.08, 1.12] <0.001 0% >0.05 [8,11
 ≤100 164 0.53 [0.19, 0.88] <0.01 0% >0.05 [10,12
HOMA-IR Adjustment for doses 
 12 g 71 0.68 [0.19, 1.17] <0.01 NA NA [11,12
 6 g 492 0.10 [−0.17, 0.38] >0.05 71% >0.05 [8,10,11
 Adjustment for subject numbers 
 >100 399 0.00 [−0.02, 0.02] >0.05 NA NA [8
 ≤100 164 0.40 [0.14, 0.66] <0.01 43% >0.05 [10,12

Publication bias

Nfs0.05 values for HbA1c, FPG, 2-hr PG, BMI, WC, HOMA-β, and HOMA-IR were higher than the number of studies included in the corresponding analyses, indicating negligible publication bias in our analyses.

Discussion

The pooled analyses indicated that Tangminling pill was more efficacious in decreasing glucose level, body weight, and improving β-cell function, with no more drug-related adverse events, than placebo treatment in T2DM patients.

Traditional Chinese medications, mainly edible herbs, have been widely used in clinical practice in China for more than 2000 years [16–18]. Ten traditional Chinese herbs were extracted and included in Tangminling pill: Rhizoma coptidis, Scutellaria baicalensis Georgi, Radix Paeoniae Alba, Rheum officinale Baill, Citrus aurantium L, Pinellia ternate, Crataegus pinnatifida Bunge, Smoked plum Fructus mume, Radix Trichosanthis and Bupleurum Chinense DC (Table 3). Three bioactive alkaloids have been isolated from Rhizoma coptidis, including berberine, coptisine, and jatrorrhizine. Berberine has numerous pharmacological effects with anti-diabetic, anti-inflammatory, anti-hypercholesterolemia, and cardioprotective properties [19–23]. Berberine displays beneficial actions in the treatment of insulin-resistant and hyperglycemic states by up-regulating adipose triglyceride lipase in adipocytes via activating adenosine 5′-monophosphate (AMP)-activated protein kinase (AMPK) signaling pathway [24,25]. It might improve glucose metabolism via inhibiting oxidation and aldose reductase. Besides, berberine might exert its anti-inflammatory action through AMPK activation, nuclear factor-κB (NF-κB) inhibition, and AP-1 pathway inhibition [26,27]. Coptisine is another bioactive component of Rhizoma coptidis, and it exhibits antioxidation, anti-osteosarcoma, anti-inflammation, neuroprotection, and anti-cancer actions through preventing interleukin-1β (IL-1β) expression, activating Akt and c-Jun N-terminal kinase (JNK)/nuclear factor erythroid 2-related factor 2 (Nrf2)/NAD(P)H:quinine oxidoreductase 1 (NQO1) signaling pathways and inhibiting lipopolysaccharide (LPS)/toll-like receptor-4 (TLR-4)-mediated pathway [28–32]. Rheum officinale Baill, the root and rhizome of Rheum palmatum L, has antioxidant, anti-platelet aggregation, and anti-inflammatory properties [33–35]. The underlying mechanism might involve reductions in the mRNA expressions of acidic mammalian chitinase and chitinase 3-like protein 4 as well as inhibition of the progression of inflammation [35]. Bupleurum Chinense DC and its bioactive ingredients, saikosaponins, exhibited immunomodulatory [36], antiviral [37], hepatoprotective [38], and anti-cancer [39] effects through inducing cell cycle arrest and cell apoptosis [40]. Moreover, albiflorin, which was extracted from Radix Paeoniae Alba or Paeonia lactiflora, exerted anti-depressant and anti-allergic effects through biosynthesis of allopregnanolone and inhibition of mast cell activation [41,42]. The main active ingredients of Scutellaria baicalensis Georgi are baicalin and wogonin, which exhibited protection of diabetes and its complications. Baicalin reduced renal fibrosis through down-regulating transforming growth factor-β/Smad pathway [43]. It also had a protective effect on T2DM via improving islet β-cell function [44]. Furthermore, wogonin alleviated diabetic cardiomyopathy, diabetes-related cognitive deficits, and metabolic syndrome [45–47]. Wogonin improved peroxisome proliferator-activated receptor (PPAR)-α (PPAR-α) activity in adipocytes and type 1 diabetic mice [48]. Flavanones naringenin and hesperetin from Citrus aurantium L exhibited anti-depressant [49], antioxidant [50], and anti-atherogenic [51] effects. Pinellia ternate had anti-cancer [52,53] and pro-inflammatory [54] actions. It also attenuated mucus secretion and airway inflammation in rats with chronic obstructive pulmonary disease [55]. Crataegus pinnatifida Bunge exerted anti-inflammatory effects [56] and decreased the risks of cardiovascular diseases by lowering blood cholesterol [57–59]. Fructus mume exhibited neuroprotective effect through down-regulating inflammation and inhibiting TLR4 and p38 MAPK signaling [60,61]. Radix Trichosanthis played anti-cancer [62] and immunosuppressive [63] roles. The combination of these components in Tangminling pill might exert more beneficial effects in T2DM patients. In our study, the safety of Tangminling pill was also confirmed, without serious adverse events reported in the included RCTs. However, the production of traditional Chinese medicine is very complicated, so it is necessary to test the effectiveness and safety of each plant extract and investigate easier preparation methods of the pill formulation.

Table 3
Major herbs and ingredients of Tangminling pill and potential mechanisms
HerbsBioactive ingredientsBeneficial effectsPotential mechanismsExperimental models used
Rhizoma coptidis Berberine - anti-inflammatory [23, 24];
- anti-hypercholesterolemia [21, 22]; blood glucose-lowering [20];
- anti-obesity [21];
- cardioprotective [19]; and antioxidative [17
- inhibiting PPAR-γ and C/EBP-α [21]; increasing adipose triglyceride lipase [20];
- inhibiting NF-κB [23, 24]; AMPK activation [22–24
Cell cultures; rodent models 
Rhizoma coptidis Coptisine - antioxidative [25];
- anti-inflammatory [26];
- neuroprotective [27];
- anti-obesity [28]; and anti-cancer [29
- preventing IL-1β expression; activating Akt and JNK/Nrf2/NQO1 pathway [25];
- inhibiting LPS/TLR-4-mediated signaling pathway [28
Cell cultures; rodent models 
Rheum officinale Baill Rhubarb - antioxidative [30];
- anti-platelet aggregation [31] and anti-inflammatory [32
- regulating inflammatory mediators [32Cell cultures; rodent models 
Bupleurum Chinense DC Saikosaponins - immunomodulatory [33]; antiviral [34];
- hepatoprotective [35];
- anti-cancer [36
- cell cycle arrest and induction of apoptosis [37Cell cultures; rodent models 
Radix Paeoniae Alba Albiflorin - antidepressant [38] and anti-allergic [39- allopregnanolone biosynthesis;
- inhibition of mast cell activation [39
Cell cultures; rodent models 
Scutellaria baicalensis Georg Baicalin - anti-fibrosis [40]; lipid-lowing; anti-hyperglycemic [41];
- alleviating diabetes-associated cognitive deficits [44
- modulating TGF-β/Smad signaling pathway [40];
- promoting islet β-cell function [41];
- modulation of MAPK sighnaling [44
Cell cultures; rodent models 
Scutellaria baicalensis Georg Wogonin - cardioprotective [42];
- anti-inflammatory [42];
- antioxidative [42];
- anti-hyperglycemic and lipid-lowering [43
- activating PPARα [43, 45];
- decreasing ROS [42]; 
Cell cultures; rodent models 
Citrus aurantium L Naringenin/hesperetin - antioxidant [47];
- antiatherogenic [48] and antidepressant [46
- increasing expression of BDNF [46];
- activating PPAR;
- up-regulating adiponectin expression [48
Cell cultures; rodent models 
Pinellia ternata Pinellia ternata lectin - pro-inflammatory [51];
- anti-cancer [49]; anti-tumor [50];
- increasing steroid biosynthesis [52
- inhibits cell proliferation and metastasis [49];
- inhibiting ERK activation [52] and activating NF-κB [51
Cell cultures; rodent models 
Crataegus pinnatifida Bunge Haw pectin pentasaccharide - anti-inflammatory [53];
- antioxidant [55];
- lowering blood cholesterol [56] and anti-atherogenic [54
- activating PPARα and acyl-CoA oxidase [55Cell cultures; rodent models 
Fructus mume Fructus mume extract - alleviating cognitive impairments [57] and anti-inflammatory [58- down-regulation of TLR4 and p38 MAPK signaling [58Cell cultures; rodent models 
Radix Trichosanthis Trichosanthin - anti-tumor [59]; anti-HIV; immunosuppressive [60- inhibiting cell growth and inducing apoptosis [59Cell cultures; rodent models 
HerbsBioactive ingredientsBeneficial effectsPotential mechanismsExperimental models used
Rhizoma coptidis Berberine - anti-inflammatory [23, 24];
- anti-hypercholesterolemia [21, 22]; blood glucose-lowering [20];
- anti-obesity [21];
- cardioprotective [19]; and antioxidative [17
- inhibiting PPAR-γ and C/EBP-α [21]; increasing adipose triglyceride lipase [20];
- inhibiting NF-κB [23, 24]; AMPK activation [22–24
Cell cultures; rodent models 
Rhizoma coptidis Coptisine - antioxidative [25];
- anti-inflammatory [26];
- neuroprotective [27];
- anti-obesity [28]; and anti-cancer [29
- preventing IL-1β expression; activating Akt and JNK/Nrf2/NQO1 pathway [25];
- inhibiting LPS/TLR-4-mediated signaling pathway [28
Cell cultures; rodent models 
Rheum officinale Baill Rhubarb - antioxidative [30];
- anti-platelet aggregation [31] and anti-inflammatory [32
- regulating inflammatory mediators [32Cell cultures; rodent models 
Bupleurum Chinense DC Saikosaponins - immunomodulatory [33]; antiviral [34];
- hepatoprotective [35];
- anti-cancer [36
- cell cycle arrest and induction of apoptosis [37Cell cultures; rodent models 
Radix Paeoniae Alba Albiflorin - antidepressant [38] and anti-allergic [39- allopregnanolone biosynthesis;
- inhibition of mast cell activation [39
Cell cultures; rodent models 
Scutellaria baicalensis Georg Baicalin - anti-fibrosis [40]; lipid-lowing; anti-hyperglycemic [41];
- alleviating diabetes-associated cognitive deficits [44
- modulating TGF-β/Smad signaling pathway [40];
- promoting islet β-cell function [41];
- modulation of MAPK sighnaling [44
Cell cultures; rodent models 
Scutellaria baicalensis Georg Wogonin - cardioprotective [42];
- anti-inflammatory [42];
- antioxidative [42];
- anti-hyperglycemic and lipid-lowering [43
- activating PPARα [43, 45];
- decreasing ROS [42]; 
Cell cultures; rodent models 
Citrus aurantium L Naringenin/hesperetin - antioxidant [47];
- antiatherogenic [48] and antidepressant [46
- increasing expression of BDNF [46];
- activating PPAR;
- up-regulating adiponectin expression [48
Cell cultures; rodent models 
Pinellia ternata Pinellia ternata lectin - pro-inflammatory [51];
- anti-cancer [49]; anti-tumor [50];
- increasing steroid biosynthesis [52
- inhibits cell proliferation and metastasis [49];
- inhibiting ERK activation [52] and activating NF-κB [51
Cell cultures; rodent models 
Crataegus pinnatifida Bunge Haw pectin pentasaccharide - anti-inflammatory [53];
- antioxidant [55];
- lowering blood cholesterol [56] and anti-atherogenic [54
- activating PPARα and acyl-CoA oxidase [55Cell cultures; rodent models 
Fructus mume Fructus mume extract - alleviating cognitive impairments [57] and anti-inflammatory [58- down-regulation of TLR4 and p38 MAPK signaling [58Cell cultures; rodent models 
Radix Trichosanthis Trichosanthin - anti-tumor [59]; anti-HIV; immunosuppressive [60- inhibiting cell growth and inducing apoptosis [59Cell cultures; rodent models 

Abbreviations: BDNF, brain derived neurophic factor; C/EBP-α, CCAAT enhancer binding protein-α; ERK, extracellular signal-regulated kinase; JNK, c-Jun N-terminal kinase; MAPK, mitogen-activated protein kinase; ROS, reactive oxygen species; TGF-β, transforming growth factor-β.

T2DM is a chronic metabolic disease in which the deterioration of glycemic control is associated with progressive islet β-cell dysfunction, chronic inflammation, oxidation, and lipid metabolic disturbance. Metabolic syndrome is characterized by the presence of abdominal obesity, IR, hyperglycemia, dyslipidemia, and hypertension [64]. Tangminling pill significantly improved pancreatic β-cell function and reduced BMI and WC in T2DM patients in our analyses. The anti-hyperglycemic effect of traditional Chinese medications might be attributed in part to the β-cell protection through activating AMPK signaling [65]. Tangminling was found to increase glucose transporter 4 (GLUT4) level and AMPK activity in skeletal muscle [66] and promote insulin secretion through up-regulating PPARα [67]. It might also promote the proliferation and differentiation of pancreatic β-cells and therefore postpone the exhaustion of β-cell function. Tangminling was showed to improve insulin sensitivity [68], which might be another potential mechanism to regulate glucose metabolic disorder.

Hypoglycemia has been considered as a major barrier to the proper glycemic control in diabetic patients [69]. Our analyses revealed that Tangminling reduced blood glucose mildly, without hypoglycemic events reported. Tangminling treatment might significantly decrease the risk of hypoglycemia, which result in a better quality of life for T2DM patients. Besides, significant heterogeneity existed in the analyses of FPG, BMI, WC, and HOMA-IR. There was a significant disparity in sample sizes among the four RCTs included in our pooled analyses. In fact, among the 767 patients included in the analyses, 399 (52.0%) were from one study [8]. However, after excluding this study, no substantial alteration was found in pooled WMDs.

Several limitations should be considered in our analyses. The sample sizes were relatively small, and the number of included studies was limited, both of which might limit the power to estimate the effects of Tangminling pill on T2DM. Intervention and follow-up durations of some studies were relatively short. Therefore, more high-quality studies with more extended intervention and larger sample sizes are needed. Despite the above limitations, this systematic analysis was more convincing than any previous single study. Indeed, our analysis has some notable strengths. It strictly adhered to the guidelines and only RCT studies were included, which helps to increase the robustness of the conclusions. In addition, the parameters used to assess the clinical outcomes are strict, which can increase the validity of our study. To the best of our knowledge, this is the first pooled analysis to assess the effect of one traditional Chinese medication, Tangminling pill, on T2DM.

Conclusion

Tangminling pill is effective and safe for glycemic control and β-cell function in T2DM patients, and it could be used to treat T2DM as a promising complementary approach. However, more rigorously designed trials are warranted to investigate the impacts of Tangminling pill on diabetes and diabetic complications.

Competing Interests

The authors declare that there are no competing interests associated with the manuscript.

Funding

This work was supported by the Clinical Medicine Science and Technology Innovation Plan of Jinan Science and Technology Bureau [grant numbers 201805080, 201805016]; the Planned Science and Technology Project of Guangdong Province [grant number 2017A020215005]; the Beijing Municipal Natural Science Foundation [grant number 7184252]; the National Natural Science Foundation [grant number 81800703]; the Bethune-Merck Diabetes Research Fund of Bethune Charitable Foundation (to J.Z. and P.H.); the China Cardiovascular Association-Advanced Research Fund [grant number 2018-CCA-AF-004]; the Cardiac Rehabilitation and Metabolic Therapy Research Fund (to P.H.); the Dyslipidemia and Atherosclerosis Research Fund (to P.H.); the China Youth Research Fund-VG Fund [grant number 2017-CCA-VG-023]; and the Key Research and Development Plan of Shandong Province [grant number 2018GSF118234].

Author Contribution

P.H. conceptualized the topic, interpreting the results and finalizing the manuscript. J.C., J.Z. and Y.L. conducted the systematic search on bibliographic databases for article retrieval, selection of articles, data extraction, and quality assessment. J.C., J.Z. and Y.L. performed the statistical analysis and wrote the manuscript draft. P.H. provided supervision of the study conduct and revised the manuscript. All authors read and approved the final manuscript.

Abbreviations

     
  • AMPK

    AMP-activated protein kinase

  •  
  • BMI

    body mass index

  •  
  • CI

    confidence interval

  •  
  • FPG

    fasting plasma glucose

  •  
  • HbA1c

    hemoglobin A1c

  •  
  • HOMA

    homeostatic model assessment

  •  
  • IR

    insulin resistance

  •  
  • I2

    inconsistency index

  •  
  • Nfs

    fail-safe number

  •  
  • PPAR

    peroxisome proliferator-activated receptor

  •  
  • RCT

    randomized controlled trial

  •  
  • T2DM

    type 2 diabetes mellitus

  •  
  • WC

    waist circumference

  •  
  • WMD

    weighted mean difference

  •  
  • 2-hr PG

    2-h postprandial glucose

References

References
1.
International Diabetes Federation
(
2017
)
International Diabetes Federation
, 8th edn,
IDF Diabetes Atlas
,
Brussels, Belgium
2.
Biggelaar
L.J.
,
Eussen
S.J.
,
Sep
S.J.
,
Mari
A
,
Ferrannini
E.
and
Dongen
M.C.
(
2017
)
Associations of dietary glucose, fructose, and sucrose with β-cell function, insulin sensitivity, and type 2 diabetes in the Maastricht study
.
Nutrients
9
,
pii: E380
,
[PubMed]
3.
Li
X.
,
Liu
Y.
,
Zheng
Y.
,
Wang
P.
and
Zhang
Y.
(
2018
)
The effect of vitamin D supplementation on glycemic control in type 2 diabetes patients: a systematic review and meta-analysis
.
Nutrients
10
,
pii: E375
4.
Almomen
S.M.
,
Guan
Q.
,
Liang
P.
,
Yang
K.
,
Sidiqi
A.M.
and
Levin
A.
(
2017
)
Daily intake of grape powder prevents the progression of kidney disease in obese type 2 diabetic ZSF1 Rats
.
Nutrients
9
,
pii: E345
,
[PubMed]
5.
Testa
R.
,
Bonfigli
A.R.
,
Prattichizzo
F.
,
La Sala
L.
,
De Nigris
V.
and
Ceriello
A.
(
2017
)
The “Metabolic Memory” theory and the early treatment of hyperglycemia in prevention of diabetic complications
.
Nutrients
9
,
pii: E437
,
[PubMed]
6.
Ma
R.C.
(
2016
)
Genetics of cardiovascular and renal complications in diabetes
.
J. Diabetes Investig.
7
,
139
154
[PubMed]
7.
Hao
P.
,
Jiang
F.
,
Cheng
J.
,
Ma
L.
,
Zhang
Y.
and
Zhao
Y.
(
2017
)
Traditional Chinese medicine for cardiovascular disease: evidence and potential mechanisms
.
J. Am. Coll. Cardiol.
69
,
2952
2966
[PubMed]
8.
Tong
X.L.
,
Wu
S.T.
,
Lian
F.M.
,
Zhao
M.
,
Zhou
S.P.
and
Chen
X.Y.
(
2013
)
The safety and effectiveness of TM81, a Chinese herbal medicine, in the treatment of type 2 diabetes: a randomized double-blind placebo-controlled trial
.
Diabetes Obes. Metab.
15
,
448
454
[PubMed]
9.
Hao
P.P.
,
Jiang
F.
,
Chen
Y.G.
,
Yang
J.
,
Zhang
K.
and
Zhang
M.X.
(
2015
)
Traditional Chinese medication for cardiovascular disease
.
Nat. Rev. Cardiol.
12
,
115
122
[PubMed]
10.
Tong
X.L.
,
Lian
F.M.
,
Zhu
Y.
,
Zhou
Q.
and
Zhen
Z.
(
2011
)
The impact of tang-min-ling pills on islet β-cell function in diabetic patients with metabolic syndrome
.
Chin. J. Diabetes
19
,
187
189
11.
Tong
X.L.
,
Ni
Q.
,
Lian
F.M.
,
Hu
J.Q.
,
Yu
F.H.
and
Ouyang
X.Q.
(
2009
)
Multi-center randomized controlled and double blind trial of Tang-min-ling pills in the treatment of type2 diabetes mellitus
.
Chin. J. Clin. Pharmacol.
25
,
104
108
12.
Zhu
Y.
,
Lian
F.M.
,
Tong
X.L.
,
Zhou
Q.
and
Zhen
Z.
(
2010
)
Effect of Tangminling pills on β-cell function of patients with type 2 diabetic combined metabolism syndrome
.
Chin. J. Inform. TCM.
17
,
14
16
13.
Hao
P.P.
,
Chen
Y.G.
,
Wang
X.L.
and
Zhang
Y.
(
2010
)
Efficacy and safety of drug-eluting stents in patients with acute ST-segment-elevation myocardial infarction: a meta-analysis of randomized controlled trials
.
Tex. Heart Inst. J.
37
,
516
524
[PubMed]
14.
Hao
P.P.
,
Zhang
M.X.
,
Li
R.J.
,
Yang
J.M.
,
Wang
J.L.
and
Chen
Y.G.
(
2011
)
Clopidogrel 150 vs. 75 mg day(-1) in patients undergoing percutaneous coronary intervention: a meta-analysis
.
J. Thromb. Haemost.
9
,
627
637
[PubMed]
15.
Cheng
J.
,
Liu
Y.
,
Li
G.
,
Zhang
Z.
,
Ma
L.
and
Yang
X.
(
2016
)
Noninvasive ventilation improves cardiac function in patients with chronic heart failure
.
Oncotarget
7
,
48918
48924
[PubMed]
16.
Li
W.L.
,
Ren
B.R.
,
Min
Z.
,
Hu
Y.
,
Lu
C.G.
and
Wu
J.L.
(
2009
)
The anti-hyperglycemic effect of plants in genus Gynura cass
.
Am. J. Chin. Med.
37
,
961
966
[PubMed]
17.
Pang
B.
,
Guo
J.
,
Zhao
L.
,
Zhao
X.
,
Zhou
Q.
and
Tong
X.
(
2016
)
Retrospective study of Traditional Chinese Medicine treatment of type 2 diabetes mellitus
.
J. Tradit. Chin. Med.
36
,
307
313
18.
Hu
Y.
,
Zhou
X.
,
Liu
P.
,
Wang
B.
,
Duan
D.M.
and
Guo
D.H.
(
2016
)
A comparison study of metformin only therapy and metformin combined with Chinese medicine jianyutangkang therapy in patients with type 2 diabetes: a randomized placebo-controlled double-blind study
.
Complement. Ther. Med.
24
,
13
18
[PubMed]
19.
Li
H.
,
He
C.
,
Wang
J.
,
Li
X.
,
Yang
Z.
and
Sun
X.
(
2016
)
Berberine activates peroxisome proliferator-activated receptor gamma to increase atherosclerotic plaque stability in Apoe-/- mice with hyperhomocysteinemia
.
J. Diabetes Investig.
7
,
824
832
[PubMed]
20.
Feng
M.
,
Zou
Z.
,
Zhou
X.
,
Hu
Y.
,
Ma
H.
and
Xiao
Y.
(
2016
)
Comparative effect of berberine and its derivative 8-cetylberberine on attenuating atherosclerosis in ApoE-/- mice
.
Int. Immunopharmacol.
43
,
195
202
[PubMed]
21.
Jin
H.
,
Jin
X.
,
Cao
B.
and
Wang
W.
(
2016
)
Berberine affects osteosarcoma via downregulating the caspase-1/IL-1beta signaling axis
.
Oncol. Rep.
37
,
729
736
[PubMed]
22.
Zhu
D.
,
Wang
S.
,
Lawless
J.
,
He
J.
and
Zheng
Z.
(
2016
)
Dose dependent dual effect of Baicalin and herb Huang Qin extract on angiogenesis
.
PLoS ONE
11
,
e0167125
[PubMed]
23.
Chang
W.
(
2016
)
Non-coding RNAs and Berberine: a new mechanism of its anti-diabetic activities
.
Eur. J. Pharmacol.
795
,
8
12
[PubMed]
24.
Huang
C.
,
Zhang
Y.
,
Gong
Z.
,
Sheng
X.
,
Li
Z.
and
Zhang
W.
(
2006
)
Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARgamma pathway
.
Biochem. Biophys. Res. Commun.
348
,
571
578
[PubMed]
25.
Lee
Y.S.
,
Kim
W.S.
,
Kim
K.H.
,
Yoon
M.J.
,
Cho
H.J.
and
Shen
Y.
(
2006
)
Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states
.
Diabetes
55
,
2256
2264
[PubMed]
26.
Amasheh
M.
,
Fromm
A.
,
Krug
S.M.
,
Amasheh
S.
,
Andres
S.
and
Zeitz
M.
(
2010
)
TNF alpha-induced and berberine-antagonized tight junction barrier impairment via tyrosine kinase, Akt and NFkappaB signaling
.
J. Cell Sci.
123
,
4145
4155
[PubMed]
27.
Jeong
H.W.
,
Hsu
K.C.
,
Lee
J.W.
,
Ham
M.
,
Huh
J.Y.
and
Shin
H.J.
(
2009
)
Berberine suppresses proinflammatory responses through AMPK activation in macrophages
.
Am. J. Physiol. Endocrinol. Metab.
296
,
E955
E964
[PubMed]
28.
Hu
Y.R.
,
Ma
H.
,
Zou
Z.Y.
,
He
K.
,
Xiao
Y.B.
and
Wang
Y.
(
2017
)
Activation of Akt and JNK/Nrf2/NQO1 pathway contributes to the protective effect of coptisine against AAPH-induced oxidative stress
.
Biomed. Pharmacother.
85
,
313
322
[PubMed]
29.
Zhou
K.
,
Hu
L.
,
Liao
W.
,
Yin
D.
and
Rui
F.
(
2016
)
Coptisine prevented IL-beta-induced expression of inflammatory mediators in chondrocytes
.
Inflammation
39
,
1558
1565
[PubMed]
30.
Friedemann
T.
,
Schumacher
U.
,
Tao
Y.
,
Leung
A.K.
and
Schroder
S.
(
2015
)
Neuroprotective activity of coptisine from Coptis chinensis (Franch)
.
Evid. Based Complement. Alternat. Med.
2015
,
827308
[PubMed]
31.
Zou
Z.Y.
,
Hu
Y.R.
,
Ma
H.
,
Wang
Y.Z.
,
He
K.
and
Xia
S.
(
2015
)
Coptisine attenuates obesity-related inflammation through LPS/TLR-4-mediated signaling pathway in Syrian golden hamsters
.
Fitoterapia
105
,
139
146
[PubMed]
32.
Yu
D.
,
Fu
S.
,
Cao
Z.
,
Bao
M.
,
Zhang
G.
and
Pan
Y.
(
2014
)
Unraveling the novel anti-osteosarcoma function of coptisine and its mechanisms
.
Toxicol. Lett.
226
,
328
336
[PubMed]
33.
Matsuda
H.
,
Morikawa
T.
,
Toguchida
I.
,
Park
J.Y.
,
Harima
S.
and
Yoshikawa
M.
(
2001
)
Antioxidant constituents from rhubarb: structural requirements of stilbenes for the activity and structures of two new anthraquinone glucosides
.
Bioorg. Med. Chem.
9
,
41
50
[PubMed]
34.
Lv
J.
,
Wang
Z.
,
Wang
Y.
,
Sun
W.
,
Zhou
J.
and
Wang
M.
(
2017
)
Renoprotective effect of the Shen-Yan-Fang-Shuai formula by inhibiting TNF-α/NF-κB signaling pathway in diabetic rats
.
J. Diabetes Res.
2017
,
1
11
35.
Chu
X.
,
Wei
M.
,
Yang
X.
,
Cao
Q.
,
Xie
X.
and
Guan
M.
(
2012
)
Effects of an anthraquinone derivative from Rheum officinale Baill, emodin, on airway responses in a murine model of asthma
.
Food. Chem. Toxicol.
50
,
2368
2375
[PubMed]
36.
Ying
Z.L.
,
Li
X.J.
,
Dang
H.
,
Wang
F.
and
Xu
X.Y.
(
2014
)
Saikosaponin-d affects the differentiation, maturation and function of monocyte-derived dendritic cells
.
Exp. Ther. Med.
7
,
1354
1358
[PubMed]
37.
Cheng
P.W.
,
Ng
L.T.
,
Chiang
L.C.
and
Lin
C.C.
(
2006
)
Antiviral effects of saikosaponins on human coronavirus 229E in vitro
.
Clin. Exp. Pharmacol. Physiol.
33
,
612
616
[PubMed]
38.
Chen
C.H.
,
Chen
M.F.
,
Huang
S.J.
,
Huang
C.Y.
,
Wang
H.K.
and
Hsieh
W.C.
(
2017
)
Saikosaponin a induces apoptosis through mitochondria-dependent pathway in hepatic stellate cells
.
Am. J. Chin. Med.
45
,
351
368
[PubMed]
39.
Kang
S.J.
,
Lee
Y.J.
,
Kim
B.M.
,
Kim
Y.J.
,
Woo
H.D.
and
Jeon
H.K.
(
2008
)
Effect of Bupleuri Radix extracts on the toxicity of 5-fluorouracil in HepG2 hepatoma cells and normal human lymphocytes
.
Basic Clin. Pharmacol. Toxicol.
103
,
305
313
[PubMed]
40.
Sun
Y.
,
Cai
T.T.
,
Zhou
X.B.
and
Xu
Q.
(
2009
)
Saikosaponin a inhibits the proliferation and activation of T cells through cell cycle arrest and induction of apoptosis
.
Int. Immunopharmacol.
9
,
978
983
[PubMed]
41.
Wang
Y.
,
Gao
S.M.
,
Li
R.
,
Zhang
M.
,
Gao
S.
and
Yu
C.Q.
(
2016
)
Antidepressant-like effects of the Radix Bupleuri and Radix Paeoniae Alba drug pair
.
Neurosci. Lett.
633
,
14
20
[PubMed]
42.
Fu
H.
,
Cheng
H.
,
Cao
G.
,
Zhang
X.
,
Tu
J.
and
Sun
M.
(
2016
)
The inhibition of mast cell activation of Radix Paeoniae alba extraction identified by TCRP based and conventional cell function assay systems
.
PLoS ONE
11
,
e0155930
[PubMed]
43.
Cai
Y.
,
Ma
W.
,
Xiao
Y.
,
Wu
B.
,
Li
X.
and
Liu
F.
(
2017
)
High doses of baicalin induces kidney injury and fibrosis through regulating TGF-β/Smad signaling pathway
.
Toxicol. Appl. Pharmacol.
333
,
1
9
[PubMed]
44.
Fu
Y.
,
Luo
J.
,
Jia
Z.
,
Zhen
W.
,
Zhou
K.
and
Gilbert
E.
(
2014
)
Baicalein protects against Type 2 diabetes via promoting islet beta-cell function in obese diabetic mice
.
Int. J. Endocrinol.
2014
,
846742
[PubMed]
45.
Khan
S.
,
Zhang
D.
,
Zhang
Y.
,
Li
M.
and
Wang
C
(
2016
)
Wogonin attenuates diabetic cardiomyopathy through its anti-inflammatory and anti-oxidative properties
.
Mol. Cell. Endocrinol.
428
,
101
108
[PubMed]
46.
Bak
E.J.
,
Kim
J.
,
Choi
Y.H.
,
Kim
J.H.
,
Lee
D.E.
and
Woo
G.H.
(
2014
)
Wogonin ameliorates hyperglycemia and dyslipidemia via PPARalpha activation in db/db mice
.
Clin. Nutr.
33
,
156
163
[PubMed]
47.
Ma
P.
,
Mao
X.Y.
,
Li
X.L.
,
Ma
Y.
,
Qiao
Y.D.
and
Liu
Z.Q.
(
2015
)
Baicalin alleviates diabetesassociated cognitive deficits via modulation of mitogen-activated protein kinase signaling, brainderived neurotrophic factor and apoptosis
.
Mol. Med. Rep.
12
,
6377
6383
[PubMed]
48.
Zhang
Y.M.
,
Li
M.X.
,
Tang
Z.
and
Wang
C.H.
(
2015
)
Wogonin suppresses osteopontin expression in adipocytes by activating PPARalpha
.
Acta Pharmacol. Sin.
36
,
987
997
[PubMed]
49.
Xing
H.
,
Zhang
K.
,
Zhang
R.
,
Shi
H.
,
Bi
K.
and
Chen
X.
(
2015
)
Antidepressant-like effect of the water extract of the fixed combination of Gardenia jasminoides, Citrus aurantium and Magnolia officinalis in a rat model of chronic unpredictable mild stress
.
Phytomedicine
22
,
1178
1185
[PubMed]
50.
Wang
Q.H.
,
Shu
Z.P.
,
Xu
B.Q.
,
Xing
N.
,
Jiao
W.J.
and
Yang
B.Y.
(
2014
)
Structural characterization and antioxidant activities of polysaccharides from Citrus aurantium L
.
Int. J. Biol. Macromol.
67
,
112
123
[PubMed]
51.
Liu
L.
,
Shan
S.
,
Zhang
K.
,
Ning
Z.Q.
,
Lu
X.P.
and
Cheng
Y.Y
(
2008
)
Naringenin and hesperetin, two flavonoids derived from Citrus aurantium up-regulate transcription of adiponectin
.
Phytother. Res.
22
,
1400
1403
[PubMed]
52.
Li
Y.
,
Li
D.
,
Chen
J.
and
Wang
S.
(
2016
)
A polysaccharide from Pinellia ternata inhibits cell proliferation and metastasis in human cholangiocarcinoma cells by targeting of Cdc42 and 67kDa Laminin Receptor (LR)
.
Int. J. Biol. Macromol.
93
,
520
525
[PubMed]
53.
Li
X.
,
Lu
P.
,
Zhang
W.
,
Li
B.
,
Yang
R.
and
Luo
K.
(
2013
)
Study on anti-Ehrlich ascites tumour effect of Pinellia ternata polysaccharide in vivo
.
Afr. J. Tradit. Complement. Altern. Med.
10
,
380
385
[PubMed]
54.
Yu
H.L.
,
Zhao
T.F.
,
Wu
H.
,
Pan
Y.Z.
,
Zhang
Q.
and
Wang
K.L.
(
2015
)
Pinellia ternata lectin exerts a pro-inflammatory effect on macrophages by inducing the release of pro-inflammatory cytokines, the activation of the nuclear factor-kappaB signaling pathway and the overproduction of reactive oxygen species
.
Int. J. Mol. Med.
36
,
1127
1135
[PubMed]
55.
Du
W.
,
Su
J.
,
Ye
D.
,
Wang
Y.
,
Huang
Q.
and
Gong
X.
(
2016
)
Pinellia ternata attenuates mucus secretion and airway inflammation after inhaled corticosteroid withdrawal in COPD rats
.
Am. J. Chin. Med.
44
,
1027
1041
[PubMed]
56.
Li
C.
and
Wang
M.H.
(
2011
)
Anti-inflammatory effect of the water fraction from hawthorn fruit on LPS-stimulated RAW 264.7 cells
.
Nutr. Res. Pract.
5
,
101
106
[PubMed]
57.
Jurikova
T.
,
Sochor
J.
,
Rop
O.
,
Mlcek
J.
,
Balla
S.
and
Szekeres
L.
(
2012
)
Polyphenolic profile and biological activity of Chinese hawthorn (Crataegus pinnatifida BUNGE) fruits
.
Molecules
17
,
14490
14509
[PubMed]
58.
Li
T.P.
,
Zhu
R.G.
,
Dong
Y.P.
,
Liu
Y.H.
,
Li
S.H.
and
Chen
G.
(
2013
)
Effects of pectin pentaoligosaccharide from Hawthorn (Crataegus pinnatifida Bunge. var. Major) on the activity and mRNA levels of enzymes involved in fatty acid oxidation in the liver of mice fed a high-fat diet
.
J. Agric. Food Chem.
61
,
7599
7605
[PubMed]
59.
Zhu
R.G.
,
Sun
Y.D.
,
Li
T.P.
,
Chen
G.
,
Peng
X.
and
Duan
W.B.
(
2015
)
Comparative effects of hawthorn (Crataegus pinnatifida Bunge) pectin and pectin hydrolyzates on the cholesterol homeostasis of hamsters fed high-cholesterol diets
.
Chem. Biol. Interact.
238
,
42
47
60.
Park
J.C.
,
Ma
J.
,
Jeon
W.K.
and
Han
J.S.
(
2016
)
Fructus mume extracts alleviate cognitive impairments in 5XFAD transgenic mice
.
BMC Complement. Altern. Med.
16
,
54
[PubMed]
61.
Lee
K.M.
,
Bang
J.
,
Kim
B.Y.
,
Lee
I.S.
,
Han
J.S.
and
Hwang
B.Y.
(
2015
)
Fructus mume alleviates chronic cerebral hypoperfusion-induced white matter and hippocampal damage via inhibition of inflammation and downregulation of TLR4 and p38 MAPK signaling
.
BMC Complement. Altern. Med.
15
,
125
[PubMed]
62.
Sha
O.
,
Niu
J.
,
Ng
T.B.
,
Cho
E.Y.
,
Fu
X.
and
Jiang
W.
(
2013
)
Anti-tumor action of trichosanthin, a type 1 ribosome-inactivating protein, employed in traditional Chinese medicine: a mini review
.
Cancer Chemother. Pharmacol.
71
,
1387
1393
[PubMed]
63.
Sun
S.
,
Wang
Y.
and
Zhou
Y.
(
2010
)
Research progress on immunosuppressive activity of monomers extracted from Chinese medicine
.
Zhong. Zhong Yao Za Zhi
35
,
393
396
64.
Ramli
N.Z.
,
Chin
K.Y.
,
Zarkasi
K.A.
and
Ahmad
F.
(
2018
)
A review on the protective effects of honey against metabolic syndrome
.
Nutrients
10
,
pii: E1009
65.
Wang
D.
,
Tian
M.
,
Qi
Y.
,
Chen
G.
,
Xu
L.
and
Zou
X.
(
2015
)
Jinlida granule inhibits palmitic acid induced-intracellular lipid accumulation and enhances autophagy in NIT-1 pancreatic β cells through AMPK activation
.
J. Ethnopharmacol.
161
,
99
107
[PubMed]
66.
Zhen
Z.
,
Chang
B.
,
Li
M.
,
Lian
F.M.
,
Chen
L.
and
Dong
L.
(
2011
)
Anti-diabetic effects of a Coptis chinensis containing new traditional Chinese medicine formula in type 2 diabetic rats
.
Am. J. Chin. Med.
39
,
53
63
[PubMed]
67.
Song
J.
,
Zhao
L.H.
,
Ji
H.Y.
,
Ji
B.W.
and
Tong
X.L.
(
2010
)
Effect of Tang Min Ling pill on PPARα and insulin secretion
.
Chin. J. Basic Med. Tradit. Chin. Med.
16
,
885
886
68.
Zhen
Z.
,
Chang
B.
,
Li
M.
,
Liu
X.Y.
,
Yu
B.
and
Liu
W.K.
(
2009
)
Influence of Kaiyuqingre formula on glycolipin metabolism in spontaneous obese T2DM rats
.
Chin. J. Tradit. Chin. Med. Pharm.
24
,
1056
1058
69.
Tascini
G.
,
Berioli
M.G.
,
Cerquiglini
L.
,
Santi
E.
,
Mancini
G.
and
Rogari
F.
(
2018
)
Carbohydrate counting in children and adolescents with type 1 diabetes
.
Nutrients
10
,
pii: E109

Author notes

*

These authors contributed equally to this work.

This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).